Trump administration reverses move to block Moderna flu vaccine trial
U-turn comes after backlash from the company and US biotech industry
Related reading
Moderna is most shorted stock in S&P 500 as Americans skip jabs
Maker of Covid-19 shots has slumped since pandemic as people turn against vaccines
US vaccine overhaul unnerves investors as sceptics seize advisory posts
Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments
US set to speed up approval for some generic drugs in blow to Big Pharma
Move is latest broadside by Trump administration against pharmaceuticals industry that fought to derail changes
FDA chief seeks to soothe US biotech fears over drug approval timeline
Commissioner says agency is hiring scientists as industry warns over delays
Return of FDA official targeted by Trump allies hits biotech shares
Food and Drug Administration reinstates Vinay Prasad who left agency in July after social media campaign
How US anti-vaxxers found they were not immune to pushback
Recent setbacks for the movement signal a potential turning point for the vaccine makers as the market picks up